The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2

Molecular and Cellular Biology

Volumn 19, Issue 8, 1999, Pages 5453-5465

  Nishimoto, Masazumi ^a   Fukushima, Akiko ^a   Okuda, Akihiko ^a   Muramatsu, Masami ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; EMBRYO CELL; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; GENE ISOLATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032797827     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.8.5453     Document Type: Article

References (52)

1. Ambrosetti, D. C., C. Basilico, and L. Dailey. 1997. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell. Biol. 17:6321-6329.
2. Arced, R. J., A. A. King, M. C. Simon, S. H. Orkin, and D. B. Wilson. 1993. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol. Cell. Biol. 13:2235-2246.
3. Bandara, L. R., and N. B. La Thangue. 1991. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351:494-497.
4. Ben-Shushan, E., J. R. Thompson, L. J. Gudas, and Y. Bergman. 1998. Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol. Cell. Biol. 18:1866-1878.
5. Botquin, V., H. Hess, G. Fuhrmann, C. Anastassiadis, M. K. Gross, G. Vriend, and H. R. Schöler. 1998. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev. 12:2073-2090.
6. Brehm, A., K. Ohbo, and H. R. Schöler. 1997. The carboxy-terminal domain of Oct-4 acquires cell specificity through the POU domain. Mol. Cell. Biol. 17:154-162.
7. Colberg-Poley, A. M., S. D. Voss, K. Chowdhury, and P. Gruss. 1985. Structural analysis of murine genes containing homeo box sequences and their expression in embryonal carcinoma cells. Nature 314:713-718.
8. Dailey, L., H. Yuan, and C. Basilico. 1994. Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol. Cell. Biol. 14:7758-7769.
9. Dent, C. L., and D. S. Latchman. 1993. The DNA mobility shift assay, p. 1-26. In D. S. Latchman (ed.), Transcription factors. IRL Press, Oxford, United Kingdom.
10. Dooley, T. P., M. Miranda, N. C. Jones, and M. L. DePamphilis. 1989. Transactivation of the adenovirus EIIa promoter in the absence of adenovirus E1A protein is restricted to mouse oocytes and preimplantation embryos. Development 107:945-956.
11. Fukushima, A., A. Okuda, M. Nishimoto, N. Seki, T. Hori, and M. Muramatsu. 1998. Characterization of functional domains of an embryonic stem cell coactivator UTF1 which are conserved and essential for potentiation of ATF-2 activity. J. Biol. Chem. 273:25840-25849.
12. Gardner, R. L., and J. Rossant. 1979. Investigation of the fate of 4-5 day postcoitum mouse inner cell mass cells by blastocyst injection. J. Embryol. Exp. Morphol. 52:141-152.
13. Gilbert, S. F. 1997. Developmental biology. Sinauer Associates, Inc., Sunderland, Mass.
14. Gunning, P., J. Leavitt, G. Muscat, S. Y. Ng, and L. Kedes. 1987. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84:4831-4835.
15. Handyside, A. H., G. T. O'Neil, M. Jones, and M. L. Hooper. 1989. Use of BRL-conditioned medium in combination with feeder layers to isolate a diploid embryonal stem cell line. Wilhelm Roux's Arch. Dev. Biol. 198:8-55.
16. Herr, W., and M. A. Cleary. 1995. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9:1679-1693.
17. Hosler, B. A., G. J. LaRosa, J. F. Grippo, and L. J. Gudas. 1989. An octamer motif contributes to the expression of the retinoic acid-regulated zinc finger gene Rex-1 (Zfp-42) in F9 teratocarcinoma cells. Mol. Cell. Biol. 9:5623-5629.
18. Imperiale, M. J., H. T. Kao, L. T. Feldman, J. R. Nevins, and S. Strickland. 1984. Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity. Mol. Cell. Biol. 4:867-874.
19. Klemm, J. D., M. A. Rould, R. Aurora, W. Herr, and C. O. Pabo. 1994. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77:21-32.
20. Kraft, H. J., S. Mosselman, H. A. Smits, P. Hohenstein, E. Piek, Q. Chen, K. Artzt, and E. J. van Zoelen. 1996. Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells. J. Biol. Chem. 271:12873-12878.
21. Kuhlbrodt, K., B. Herbarth, E. Sock, J. Enderich, I. Hermans-Borgmeyer, and M. Wegner. 1998. Cooperative function of POU proteins and SOX proteins in glial cells. J. Biol. Chem. 273:16050-16057.
22. La Thangue, N. B., and P. W. J. Rigby. 1987. An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell 49:507-513.
23. LaRosa, G. J., and L. J. Gudas. 1988. An early effect of retinoic acid: cloning of an mRNA (Era-1) exhibiting rapid and protein synthesis-independent induction during teratocarcinoma stem cell differentiation. Proc. Natl. Acad. Sci. USA 85:329-333.
24. Leger, H., E. Sock, K. Renner, F. Grummt, and M. Wegner. 1995. Functional interaction between the POU domain protein Tst-1/Oct-6 and the high mobility-group protein HMG-I/Y. Mol. Cell. Biol. 15:3738-3747.
25. Liu, L., and R. M. Roberts. 1996. Silencing of the gene for the beta subunit of human gonadotropin by the embryonic transcription factor Oct 3/4. J. Biol. Chem. 271:16683-16689.
26. Majumder, S., and M. L. DePamphilis. 1995. A unique role for enhancers is revealed during early mouse development. Bioessays 17:879-889.
27. Majumder, S., Z. Zhao, K. Kaneko, and M. L. DePamphilis. 1997. Developmental acquisition of enhancer function requires coactivator activity. EMBO J. 16:1721-1731.
28. Maruyama, K., and S. Sugano. 1994. Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene 138:171-174.
29. Martin, G. R. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78:7634-7638.
30. Murphy, S. P., J. Garbern, W. F. Odenwald, R. A. Lazzarini, and E. Linney. 1988. Differential expression of the homeobox gene Hox-1.3 in F9 embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 85:5587-5591.
31. Murray, E. J., D. Stott, and P. W. J. Rigby. 1991. Sequences and factors required for the F9 embryonal carcinoma stem cell E1a-like activity. Mol. Cell. Biol. 11:5534-5540.
32. Nichols, J., B. Zevnik, K. Anastassiadis, H. Niwa, D. Klewe-Nebenius, I. Chambers, H. R. Schöler, and A. Smith. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct-4. Cell 95:379-391.
33. Nishimoto, M., and M. Muramatsu. Unpublished data.
34. Nishimoto, M., Y. Suzuki, S. Sugano, and M. Muramatsu. Unpublished data.
35. Okamoto, K., H. Okazawa, A. Okuda, M. Sakai, M. Muramatsu, and H. Hamada. 1990. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60:461-472.
36. Okuda, A., A. Fukushima, M. Nishimoto, A. Orimo, T. Yamagishi, Y. Nabeshima, M. Kuro-o, Y. Nabeshima, K. Boon, M. Keaveney, H. G. Stunnenberg, and M. Muramatsu. 1998. UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells. EMBO J. 17:2019-2032.
37. Pevny, L. H., and R. Lovell-Badge. 1997. Sox genes find their feet. Curr. Opin. Genet. Dev. 7:338-344.
38. Pinney, D. F., S. H. Pearson-White, S. F. Konieczny, K. E. Latham, and C. P. Emerson, Jr. 1988. Myogenic lineage determination and differentiation: evidence for a regulatory gene pathway. Cell 53:781-793.
39. Robertson, E. J. 1987. Embryo-derived stem cell lines, p. 71-112. In E. J. Robertson (ed.), Teratocarcinoma and embryonic stem cell. IRL Press, Oxford, United Kingdom.
40. Rogers, M. B., B. A. Hosler, and L. J. Gudas. 1991. Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. Development 113:815-824.
41. Rosner, M. H., M. A. Vigano, K. Ozato, P. M. Timmons, F. Poirier, P. W. J. Rigby, and L. M. Staudt. 1990. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345:686-692.
42. Saijoh, Y., H. Fujii, M. Meno, M. Sato, Y. Hirota, S. Nagamitsu, M. Ikeda, and H. Hamada. 1996. Identification of putative downstream genes of Oct-3, a pluripotent cell-specific transcription factor. Genes Cells 1:239-252.
43. Schöler, H. R., S. Ruppert, N. Suzuki, K. Chowdhury, and P. Gruss. 1990. New type of POU domain in germ line-specific protein Oct-4. Nature 344: 435-439.
44. Schöler, H. R., T. Cicsiolka, and P. Gruss. 1991. A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells. Cell 66:291-304.
45. Suzuki, N., H. Rohdewohld, T. Neuman, P. Gruss, and H. R. Schöler. 1990. Oct-6: a POU transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J. 9:3723-3732.
46. Verrijzer, C. P., and P. C. Van der Vliet. 1993. POU domain transcription factors. Biochim. Biophys. Acta 1173:1-21.
47. Williams, R. L., D. J. Hilton, S. Pease, T. A. Willson, C. L. Stewart, D. P. Gearing, E. F. Wagner, D. Metcalf, N. A. Nicola, and N. M. Gough. 1988. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336:684-687.
48. Xin, J. H., A. Cowie, P. Lachance, and J. A. Hassell. 1992. Molecular cloning and characterization of PEA3, a new member of the Els oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev. 6:481-496.
49. Yoam, Y. I., G. Fuhrmann, C. E. Ovitt, A. Brehm, K. Ohbo, M. Gross, K. Hübner, and H. R. Schöler. 1996. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122:881-894.
50. Yuan, H., N. Corbi, C. Basilico, and L. Dailey. 1995. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9:2635-2645.
51. Zwart, R., L. Broos, G. Grosveld, and D. Meijer. 1996. The restricted expression pattern of the POU factor Oct-6 during early development of the mouse nervous system. Mech. Dev. 54:185-194.
52. Zwilling, S., H. Konig, and T. Wirth. 1995. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 14:1198-1208.